Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pld1tm3Mafr mutation
(0 available);
any
Pld1 mutation
(64 available)
|
|
|
hematopoietic system
|
• integrin activation is slightly reduced upon stimulation with low and intermediate concentrations of thrombin or protease-activated receptor 4 (PAR4)-activating peptide
• however, no defect in integrin activation is noted upon submaximal platelet activation with collagen-related peptide (CRP)
|
homeostasis/metabolism
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pld1tm3Mafr mutation
(0 available);
any
Pld1 mutation
(64 available)
|
|
|
mortality/aging
|
• following induction of lethal pulmonary thromboembolism with collagen and epinephrine
|
homeostasis/metabolism
hematopoietic system
|
• unstable under high shear flow conditions
• however, aggregation under low and intermediate shear conditions is normal
|
nervous system
|
• following focal cerebral ischemia, mice exhibit decreased infarct size, no intracranial hemorrhage and improved motor function and coordination compared with wild-type mice
• however, mice reconstituted with wild-type bone marrow exhibit normal infarcts
|
|
• following focal cerebral ischemia
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pld1tm3Mafr mutation
(0 available);
any
Pld1 mutation
(64 available)
Pld2tm1(KOMP)Vlcg mutation
(0 available);
any
Pld2 mutation
(48 available)
|
|
|
homeostasis/metabolism
hematopoietic system
|
• platelets show reduced alpha-granule release upon stimulation of protease-activated receptor 4 (PAR4) with either thrombin or PAR4-activating peptide, as determined by the levels of surface exposed P-selectin
• secretion of the alpha-granular proteins von Willebrand factor (VWF) and platelet factor 4 (PF4) is decreased relative to that in wild-type platelets
• integrin activation is markedly reduced upon stimulation with low and intermediate concentrations of thrombin or PAR4-activating peptide
• no differences in reactivity are observed in aggregometry
• the amount and localization of alpha granules and agonist-induced ATP release (a measure of dense granule secretion) are normal
|
nervous system
|
• in the transient middle cerebral artery occlusion (tMCAO) model, brain infarct volume is reduced to ~60% of that in wild-type controls and the neurologic Bederson score is significantly improved 24 h after tMCAO, indicating protection from ischemic stroke
|
|
• at 24 h after tMCAO, brain infarct volume is reduced to ~60% of that in wild-type controls
|